semaglutide injection therapy vial

Semaglutide Injections Prescribed Online

Plans Starting at $249.99 a month

✔ May help with weight loss
✔ Reduces risk of cardiovascular events
✔ Get your prescription in 15 minutes
✔ FSA and HSA accepted
✔ Medication delivered to your door


What is Compounded Semaglutide?

At Bee Well, we prioritize personalized healthcare solutions. Our compounded semaglutide, a GLP-1 agonist, is meticulously crafted in collaboration with state-licensed compounding pharmacies. This medication works by mimicking your body's natural hormones, facilitating a sensation of fullness that comes quicker and lingers longer. This once-weekly shot not only complements your weight loss efforts but also plays a crucial role in addressing other health issues.

It is tailored to individual prescriptions from our licensed healthcare professionals, offering flexibility in dosage, administration, and efficacy. Bee Well is dedicated to working exclusively with reputable compounding pharmacies, guaranteeing the use of FDA-licensed ingredients and upholding the highest standards in pharmaceutical compounding.

Please note that semaglutide is not indicated for individuals with type 1 diabetes and is not recommended for use in children under 18 years of age. Semaglutide is FDA-approved for type 2 diabetes treatment, but may be prescribed for weight loss.

How It Works

Plans starting at just $249.99 a month* - No Insurance Needed + FSA or HSA Accepted

1. Schedule your 15-minute consultation

schedule your 15 minute consultation with our licensed healthcare professional today

2. Connect with our doctor via a telehealth call

telehealth doctor having weight loss consultation

3. Receive your prescription

semaglutide needles

*up to maintaining level of 0.5mg dosage

FAQs

  • To obtain Semaglutide, you'll need to schedule a consultation priced at $49.99. We have plans starting at $249.99 for up to 1mg dosage. If your prescription is greater than 1mg dosage, prices increase to $349.99+. We accept HSA or FSA cards as a form of payment.

  • Semaglutide is part of the glucagon-like peptide-1 (GLP-1) inhibitor medication class. After injecting a dose, it acts like the incretin GLP-1.

    Similarly, Tirzepatide acts like GLP-1 in the body. However, it also mimics an incretin called glucose-dependent insulinotropic polypeptide (GIP). So it belongs to a different medication class: dual GIP/GLP-1 agonists. Medications in this class can help provide better blood glucose control than GLP-1 agonists for people with Type 2 diabetes.

  • Semaglutide may cause the following side effects: diarrhea, constipation, headaches, nausea, bloating, heartburn, stomach discomfort, or fullness

  • Following your virtual consultation with our medical professional, if you're a suitable candidate for treatment, we'll send your prescription to our partner pharmacy that will create your personalized medication and cold ship it to you within 2 weeks.

  • Semaglutide is injected into fatty tissue. Common injection sites include the abdomen, sides or back of the upper arms, and the front of the thighs.

  • With proper diet, weight loss can begin within the first week of treatment. Some of our patients have seen 1-3 lbs of weight loss per week, but results vary from person to person.

  • For optimal results, we suggest adopting healthier eating habits and engaging in regular physical activity. Emphasizing a diet rich in protein, healthy fats, and fiber, while minimizing processed foods, is highly recommended.

  • Maintaining a stable weight after discontinuing Semeaglutide and Tirzepatide is possible, thanks to the positive lifestyle changes these medications encourage. However, returning to unhealthy eating and lifestyle habits may lead to weight gain.

  • After the initial month of treatment, we will send you a follow-up form that you will fill out to track your progress. If you’re pleased with your journey, then we’ll prescribe your next month’s dosage. If you’re unhappy with your progress so far, we’ll ask you schedule a follow up consultation with our healthcare professional to re-evaluate your treatment. We'll sustain monthly monitoring, and our doctors are always available to address any queries you might have.

  • To ensure the optimal storage of semaglutide or tirzepatide, it's crucial to maintain a temperature range of 36°F to 46°F (2°C to 8°C). Keep the medication in their original packaging to shield them from light, and be cautious not to freeze them, as this can compromise their efficacy. Due to the medication containing glass parts, handle them with care. If a medication is accidentally dropped on a hard surface, it should not be used, and a new pen should be used for the injection. Be mindful of variations in refrigerator temperature, as some areas may be colder than others. Always check the medication before use to ensure it hasn't frozen. Notably, medications can last unrefrigerated for up to 21 days, provided the temperature doesn't exceed 86°F (30°C). It's advisable to store the pen in its original carton to protect it from light during this period.

Other GLP-1 Weight Loss Treatments

Find the most effective medication for your weight loss journey, with help from our licensed healthcare professionals.

NEW!

Oral Semaglutide

Daily Pill Dissolving Under Tongue
Only $375 for 30 pills

Semaglutide is the active pharmaceutical ingredient in Ozempic® and Wegovy® that has supported numerous individuals in achieving and sustaining weight loss when integrated with a healthy diet and regular exercise. Bee Well offers compounded oral semaglutide.

Learn More

Prescription products require a provider consultation.

Tirzepatide Weekly Injections

Plans starting at $299.99 per month

Tirzepatide is the active pharmaceutical ingredient used in Mounjaro® and Zepbound™ that has supported numerous individuals in achieving and sustaining weight loss when integrated with a healthy diet and regular exercise. Bee Well offers compounded tirzepatide.

Learn More

Prescription products require a provider consultation.

Important Safety Information

Do not share your semaglutide needle with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

What is the FDA-approved use of semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that is used:

  • with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.

  • to reduce the risk of major adverse cardiovascular events in patients with type 2 diabetes mellitus and established cardiovascular disease.

Limitations of Use:

  • semaglutide has not been studied in patients with a history of pancreatitis.

  • semaglutide is not for treatment of type 1 diabetes mellitus.

Your Bee Well-affiliated provider may recommend the use of semaglutide as treatment for chronic weight management (obesity or overweight).

Do not use semaglutide if:

  • You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

  • You have a known allergic reaction to semaglutide (the active ingredient in Wegovy or Ozempic).

How should semaglutide be administered?

You can take semaglutide with or without food. The medication in the needle is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. Your Bee Well-affiliated provider will guide you on a treatment regimen that may include an increase in dose every four weeks.

You should not change your dosing regimen or stop taking semaglutide as prescribed without discussing with your provider first.

What should I tell my Bee Well-affiliated provider before using semaglutide?

Semaglutide has certain drug interactions. It’s important to tell your Bee Well-affiliated provider all of the medications you are currently taking, including prescription, over-the-counter medications, vitamins, and herbal and dietary supplements.

Some medications to watch out for include:

  • Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL)

  • Ozempic causes a delay in gastric emptying so it has the potential to impact the absorption of medications that are taken by mouth at the same time. Your provider can guide you on how to schedule your medications.

  • Other GLP-1 medications, including Wegovy, Saxenda, Victoza, Byetta, or Bydureon

  • If you’re using other products for weight loss, including dietary supplements

It’s important to share your entire medical history with your provider. In particular, tell your provider if you have a past history of:

  • Type 1 or type 2 diabetes

  • Thyroid cancer

  • Pancreatitis

  • Kidney disease

  • Diabetic retinopathy

  • Depression

  • Suicidal thoughts or behavior

Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding.

  • If you are pregnant: semaglutide should not be used during pregnancy. Based on animal studies, there may be potential risks to an unborn baby from exposure to semaglutide during pregnancy. There is no benefit to weight loss during pregnancy and it may cause harm to the unborn baby.

  • If you are a female or male of reproductive potential: Discontinue semaglutide at least 2 months before a planned pregnancy since the drug can stay in the bloodstream for a long time.

  • If you are breastfeeding: semaglutide was found in the milk of lactating rats. Tell your Bee Well-affiliated provider if you are breastfeeding before you start semaglutide.

Pregnancy registry: There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to semaglutide (the active ingredient in Ozempic and Ozempic) during pregnancy. Pregnant women exposed to semaglutide and healthcare providers are encouraged to contact Novo Nordisk at 1-800-727-6500.

Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.

What are the most serious side effects that I or a caregiver should monitor for when taking semaglutide?

If you are experiencing a medical emergency, call 911 or seek immediate medical attention.

These serious side effects can occur with semaglutide. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.

  • Thyroid C-Cell Tumors: In mice and rats, semaglutide (the active ingredient in Ozempic) caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is unknown whether semaglutide causes thyroid C-cell tumors in humans. There were cases of MTC reported in patients who took liraglutide (the active ingredient in Victoza and Saxenda) after the drug was put on the market. Ozempic is contraindicated in patients with a family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.

  • Inflammation of Pancreas (Acute Pancreatitis): Monitor for signs of acute pancreatitis, including severe abdominal pain that does not go away, sometimes radiating to the back, with or without vomiting.

  • Diabetic Retinopathy Complications in Patients with Type 2 Diabetes: If you have type 2 diabetes, tell your provider right away if you experience changes in vision.

  • Never Share a Needle: Needle-sharing poses a risk of infection.

  • Low Blood Sugar (hypoglycemia): Semaglutide lowers blood glucose. It can cause too low blood sugar in patients with type 2 diabetes who also take another glucose control medication. Monitor your blood sugar and watch out for signs of too low blood sugar such as dizziness, blurred vision, mood changes, sweating, or fast heartbeat.

  • Acute Kidney Injury: In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink plenty of water to help reduce your chance of dehydration.

  • Serious Allergic Reactions: Stop using semaglutide right away if you experience symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, severe rash or itching, very rapid heartbeat, problems breathing or swallowing, or fainting or feeling dizzy.

  • Acute Gallbladder Disease: Semaglutide may cause gallbladder problems, including gallstones. Some gallbladder problems require surgery. Tell your provider right away if you have pain in your upper stomach, yellowing of skin or eyes (jaundice), fever, or clay-colored stools.

  • Increase in Heart Rate: Tell your provider right away if you have a racing heartbeat while at rest.

  • Suicidal Behavior and Ideation: You should pay attention to any mental health changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.

This information is not comprehensive. Please see the full Prescribing Information for complete safety information.